- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04256798
Perioperativ andningsvård och resultat för patienter som genomgår högriskbukkirurgi (PENGUIN)
PERioperativ andningsvård och resultat för patienter som genomgår högriskabdominal kirurgi: en 2x2 faktoriell, internationell pragmatisk randomiserad kontrollerad studie i låg- och medelinkomstländer
PENGUIN is a pragmatic multi-center trial investigating the effects of pre-operative mouthwash and perioperative oxygen on the incidences of pneumonia and surgical site infection (SSI) following major abdominal surgery.
Patients will be recruited from low and middle income countries and randomly assigned to a trial treatment arms: a) pre-operative chlorhexidine mouthwash and 80-100% FiO2; b) no pre-operative mouthwash and 80-100% fraction of inspired oxygen (FiO2); c) pre-operative chlorhexidine mouthwash and 21- 30% FiO2; or d) no pre-operative mouthwash and 21-30% FiO2.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
PENGUIN is a pragmatic, blinded (outcome assessor), 2x2 factorial, multi-centre randomised controlled trial, with an internal pilot, to evaluate measures to reduce surgical site infection (SSI) and pneumonia rates in patients undergoing surgery with an abdominal incision.
Pneumonia is one of the most serious complications to occur after surgery, accounting for up to one in four of all postoperative deaths. The incidence is greater still in high-risk populations such as those undergoing midline laparotomy where mortality rates are more than 10%. SSIs are clearly important being the most frequent healthcare-associated infection in LMICs, affecting one in three patients undergoing contaminated or dirty surgery (34, 35). SSIs cause pain, discomfort and disability. They increase the time taken to return to work, and healthcare costs
The risk of postoperative mortality and complications such as surgical site infection is three times greater in low and middle-income countries (LMICs) than in high-income countries. In order to address surgical need worldwide, it is estimated that provision of a further 312 million operations would be required each year.
Patients will be recruited from hospitals in Low and Middle Income Countries (LMICs) who are undergoing elective or emergency mid-line laparotomy. Eligible patients will be randomised at the level of the individual in a 1:1:1:1 ratio between:
A. Preoperative chlorhexidine mouthwash and 80-100% FiO2 during surgery B. No preoperative chlorhexidine mouthwash and 80-100% FiO2 during surgery C. Preoperative chlorhexidine mouthwash and 21-30% FiO2 during surgery D. No preoperative chlorhexidine mouthwash and 21-30% FiO2 during surgery
The 6 month internal pilot will assess the feasibility of recruitment, compliance with treatment allocation and patient retention and follow-up rates. The main Randomised Control Trial will recruit 12,924 participants.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 3
Kontakter och platser
Studieorter
-
-
-
Porto Alegre, Brasilien
- Hospital de Clinicas de Porto Alegre
-
Porto Alegre, Brasilien
- Hospital Nossa Senhora da Conceicao
-
Salvador, Brasilien
- Hospital Universitario Professor Edgar Santos/Bahia
-
São José, Brasilien
- Hospital Sao Jose - Criciuma/SC
-
-
São Paulo
-
Botucatu, São Paulo, Brasilien
- Hospital das Clinicas da Faculdade de Medicina de Botucatu - UNESP
-
-
-
-
-
Bhubaneswar, Indien, 751019
- All India Institute of Medical Sciences, Bhubaneswar
-
Chandigarh, Indien, 160047
- Government Medial College & Hospital, Chandigarh
-
Jodhpur, Indien, 342005
- All India Institute of Medical Sciences, Jodhpur
-
Kolkata, Indien, 700160
- Tata Medical Center
-
Ludhiana, Indien, 141008
- Christian Medical College (CMC) & Hospital, Ludhiana
-
Madhepura, Indien, 852113
- Madhepura Christian Hospital
-
Mumbai, Indien, 400012
- Tata Memorial Hospital
-
Mumbai, Indien, 400008
- Topiwala National Medical College and Bai Yamunabai Laxman Nair Charitable Hospital
-
New Delhi, Indien, 110002
- Maulana Azad Medical College
-
Rishikesh, Indien, 249203
- All India Institute of Medical Sciences, Rishikesh
-
Vellore, Indien, 632004
- Christian Medical College & Hospital Vellore
-
-
Andhra Pradesh
-
Visakhapatnam, Andhra Pradesh, Indien, 530053
- Homi Bhabha Cancer Hospital & Research Centre
-
-
Jammu and Kashmir
-
Srinagar, Jammu and Kashmir, Indien, 190011
- Sher - i - Kashmir Institute of Medical Sciences
-
-
Maharashtra
-
Chinchpāda, Maharashtra, Indien, 425417
- Chinchpada Christian Hospital
-
-
Manipal, Karnataka
-
Madhava Nagar, Manipal, Karnataka, Indien, 576104
- Kasturba Medical College Hospital, Manipal
-
-
Punjab
-
Patiāla, Punjab, Indien, 147001
- Government Medical College, Patiala
-
-
-
-
-
Belisario Domínguez, Mexiko, 44329
- Centro Médico Nacional de Occidente IMSS
-
Veracruz, Mexiko, 91700
- Hospital Espanola Veracruz
-
-
-
-
-
Benin City, Nigeria, 300283
- University of Benin Teaching Hospital
-
Gwagwalada, Nigeria, 902101
- University Of Abuja Teaching Hospital
-
Ibadan, Nigeria, 200285
- University College Hospital
-
Ile-Ife, Nigeria, 233285
- Obafemi Awolowo University Teaching Hospitals Complex
-
Ilorin, Nigeria, 241102
- University of Ilorin Teaching Hospital
-
Kaduna, Nigeria, 810105
- Ahmadu Bello University Teaching Hospital
-
Kano, Nigeria, 700101
- Aminu Kano Teaching Hospital
-
Lagos, Nigeria, 102215
- Lagos University Teaching Hospital
-
Lagos, Nigeria, 101233
- Lagos State University Teaching Hospital
-
Nnewi, Nigeria, 435101
- Nnamdi Azikiwe University Teaching Hospital
-
-
-
-
-
Kigali, Rwanda
- University Teaching Hospital Kigali
-
-
-
-
-
Cape Town, Sydafrika, 7505
- Tygerberg Hospital
-
Cape Town, Sydafrika, 7925
- Groote Schuur Hospital
-
Cape Town, Sydafrika, 8001
- New Somerset Hospital
-
Paarl, Sydafrika, 7646
- Paarl Provincial Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Adults and children aged 10 years or over
- Elective or emergency abdominal surgery via midline laparotomy with an anticipated abdominal incision of at least 5cm in length
- Written informed consent of patient (signature or a fingerprint)
Exclusion Criteria:
- Patients undergoing caesarean section
- Patients with a documented or suspected allergy to chlorhexidine
- Patient unable to complete postoperative follow-up (not contactable after discharge)
- Previous enrolment in PENGUIN within the past 30 days
- American Society of Anesthesiologists (ASA) grade V patients (expected to die with or without surgery)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Mouthwash and liberal oxygen during surgery
Pre-surgical mouthwash with 0.2% chlorhexidine gluconate in combination with 80-100% FiO2 during surgery. |
0.2% Chlorhexidine digluconate Oxygen 80-100% Oxygen 21-30 % |
|
Aktiv komparator: No mouthwash and liberal oxygen during surgery
No pre-surgical mouthwash in combination with 80-100% FiO2 during surgery. |
Oxygen 80-100% Oxygen 21-30 % |
|
Experimentell: Mouthwash and restrictive oxygen during surgery
Pre-surgical mouthwash with 0.2% chlorhexidine gluconate in combination with 21-30% FiO2 during surgery. |
0.2% Chlorhexidine digluconate Oxygen 80-100% Oxygen 21-30 % |
|
Aktiv komparator: No mouthwash and restrictive oxygen during surgery
No pre-surgical mouthwash in combination with 21-30% FiO2 during surgery. |
Oxygen 80-100% Oxygen 21-30 % |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of participants with pneumonia using the US Centers for Disease Control (CDC) definition of pneumonia (Mouthwash intervention only)
Tidsram: Within 30 days post-surgery from index operation
|
Pneumonia will be classified using the US Centers for Disease Control (CDC) definition of pneumonia |
Within 30 days post-surgery from index operation
|
|
Number of participants with surgical site infection (Oxygen therapy intervention only)
Tidsram: Within 30 days post-surgery from index operation
|
The infection must involve the skin, subcutaneous, muscular or fascial layers of the incision AND The patient must have at least one of the following:
|
Within 30 days post-surgery from index operation
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Number of trial participant moralities (Mouthwash and oxygen therapy intervention comparisons)
Tidsram: Within 30 days post-surgery from index operation
|
Patient mortality status |
Within 30 days post-surgery from index operation
|
|
Number of participants who received repeat abdominal surgery to treat complications (Oxygen therapy intervention only)
Tidsram: Within 30 days post-surgery from index operation
|
Repeat abdominal surgery to treat complications |
Within 30 days post-surgery from index operation
|
|
Number of participants who received repeat abdominal surgery (Mouthwash and oxygen therapy interventions)
Tidsram: Within 30 days post-surgery from index operation
|
Repeat abdominal surgery |
Within 30 days post-surgery from index operation
|
|
Length of hospital stay for index admission (Mouthwash and oxygen therapy interventions)
Tidsram: Within 30-days post surgery from index operation
|
Length of hospital stay for index admission will be collected and will measure time from surgery to time of discharge. |
Within 30-days post surgery from index operation
|
|
Number of participants returning to normal activities (Mouthwash and oxygen therapy interventions)
Tidsram: Within 30 days post-surgery from index operation
|
Return to normal activities (e.g. work, school, or family duties) ascertained by trial specific case report forms. |
Within 30 days post-surgery from index operation
|
|
Number of participants admissions to a critical care unit (Mouthwash and oxygen therapy interventions)
Tidsram: Within 30 days post-surgery from index operation
|
Admission to a critical care unit will be captured on the trial case report forms. |
Within 30 days post-surgery from index operation
|
|
Health resource usage per patient
Tidsram: Within 30 days post-surgery from index operation
|
Resource use data will be collected as part of the economic evaluation of the different treatment combinations in a sub-group of adult patients at selected centers. Information related to post-operative cost (medicinal products, amenities and personal) will be collected on a health resource usage case report form designed by the trials health economist. |
Within 30 days post-surgery from index operation
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Rupert Pearse, Royal London Hospital
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Sjukdomsegenskaper
- Luftvägsinfektioner
- Luftvägssjukdomar
- Lungsjukdomar
- Patologiska tillstånd, tecken och symtom
- Lunginflammation
- Infektioner
- Smittsamma sjukdomar
- Patologiska processer
- Kirurgisk sårinfektion
- Sårinfektion
- Postoperativa komplikationer
- Oorganiska kemikalier
- Element
- Kalkogener
- Gaser
- Syre
Andra studie-ID-nummer
- RG_19-223
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Data will be shared via a process of controlled access
Tidsram för IPD-delning
6 months post publication
Kriterier för IPD Sharing Access
Formal requests must be submitted to the Data Access Group at Birmingham Clinical Trials Unit
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- ICF
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .